Yabao Pharmaceutical Group Co Ltd (600351.SS)

600351.SS on Shanghai Stock Exchange

22 Jan 2018
Change (% chg)

¥0.06 (+0.84%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low

Select another date:

Mon, Dec 25 2017

BRIEF-Yabao Pharma Sees 2017 Net Profit Up 788-818 Pct On Rising Sales Of High Margin Products

* SAYS IT SEES 2017 NET PROFIT UP 788-818 PERCENT Y/Y FROM 225.2 MILLION YUAN ($34.44 million) YEAR AGO Source text in Chinese: http://bit.ly/2l7xYmF Further company coverage: ($1 = 6.5385 Chinese yuan renminbi) (Reporting by Hong Kong newsroom)

BRIEF-Yabao Pharma's controlling shareholder plans exchangeable bonds issue

* Says controlling shareholder plans to raise up to 500 million yuan ($75.33 million) in exchangeable bonds issue

BRIEF-Yabao Pharmaceutical Group gets approval to conduct drug clinical trials for diabetes

* Says it gets an approval to conduct drug clinical trials of SY-008 which can be used for treatment of diabetes, from China Food and Drug Administration

Select another date: